Tag:
SV Life Sciences Advisers
Latest Headlines
Latest Headlines
Google contributes to $14M round for fast-growing Adimab
Fast-growing Adimab has added close to $14 million in venture cash to the bank as it hires on new staffers and preps for a move into a 21,500-square-foot lab in Lebanon, NH.
Lundbeckfond contributes to $25M B round for AlloCure's Phase II stem cell study
Lundbeckfond Ventures has stepped in to lead a $25 million venture round for AlloCure, a Burlington, MA-based stem cell company.
Investors ready to craft new biotechs out of Pfizer's discards
While the life sciences sector in the UK is still reeling from Pfizer's decision to pull out of Sandwich and chop 2,400 researchers from its payroll, some investor groups are preparing to make
SV Life Sciences flush with venture cash, bullish on exit deals
Boston-based SV Life Sciences , an active investor in the biotech scene, is flush with cash and its partners are practically bubbling with excitement over the improved prospects for cashing out of
